Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease
Avastin Increases Overall Survival 3.7 Months
First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma
Phase III Trial of ThermoDox Fails to Meet Primary Endpoint
Neulasta Reduces Incidence Of Febrile Neutropenia
Tivozanib Does Not Improve OS Compared to Sorafenib
In Surgery vs Radiotherapy, Outcome Differences Equalize After 15 Years Follow-up
Genomic Test More Accurate In Predicting Metastasis Than PSA, Tumor Stage & Grade
Protein May Link Obesity To Cancer Aggressiveness
“Triple-Negative” Should Be Split Into Subtypes, Say Researchers
NCI CTEP Approved Trials For the Month of February
Avastin Combination Approved For Metastatic Colorectal Cancer
FDA Grants Priority Review To Two Drugs in NSCLC
Trending Stories
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Duke brain cancer researcher Kyle Walsh named director of NIEHS
- Trump cuts IVF drug deal with Merck in exchange for tariff exemption
- Science advocates organize march in DC to demand impeachment of RFK Jr.
- Friends study points to ctDNA’s potential to serve as an intermediate endpoint in NSCLC
ctMoniTR project aims to improve efficiency in development of intermediate endpoints - Experts warn that loss of carcinogen surveillance threatens to increase cancer incidence
